Gastric cancer in patients with type I gastric carcinoids

Gastric Cancer

Volumn 18, Issue 3, 2015, Pages 564-570

  Lahner, Edith ^a   Esposito, Gianluca ^a   Pilozzi, Emanuela ^a   Galli, Gloria ^a   Corleto, Vito D ^a,b   Di Giulio, Emilio ^a   Annibale, Bruno ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b FATEBENEFRATELLI HOSPITAL   (Italy)

Author keywords

Atrophic body gastritis; Autoimmune gastritis; Gastric cancer; Pernicious anemia; Type I gastric carcinoids

Indexed keywords

ADULT; AGED; ARTICLE; ATROPHIC BODY GASTRITIS; AUTOIMMUNE THYROIDITIS; CASE STUDY; CLINICAL ARTICLE; COHORT ANALYSIS; FEMALE; GASTRITIS; GASTROSCOPY; HUMAN; MALE; MIDDLE AGED; PERNICIOUS ANEMIA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SIGNET RING CARCINOMA; STOMACH ADENOCARCINOMA; STOMACH CARCINOID; STOMACH CARCINOMA; TUMOR BIOPSY; ATROPHIC GASTRITIS; CARCINOID TUMOR; COMPLICATION; FOLLOW UP; PATHOLOGY; STOMACH NEOPLASMS;

ADULT; AGED; CARCINOID TUMOR; FEMALE; FOLLOW-UP STUDIES; GASTRITIS, ATROPHIC; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS;

EID: 84938955602     PISSN: 14363291     EISSN: 14363305     Source Type: Journal    
DOI: 10.1007/s10120-014-0393-8     Document Type: Article

References (43)

1. Delle Fave G, Kwekkeboom DJ, Van Cutsem E, et al. ENETS consensus guidelines for the management of patients with gastroduodenal neoplasms. Neuroendocrinology. 2012;95:74–87.
2. Bosman FT et al. WHO Classification of Tumours of the Digestive System, IARC press, 2010.
3. Bordi C, D’Adda T, Azzoni C, et al. Pathogenesis of ECL cell tumors in humans. Yale J Biol Med. 1998;71:273–84.
4. Dockray GJ, Varro A, Dimaline R, et al. The gastrins: their production and biological activities. Annu Rev Physiol. 2001;63:119–39.
5. Bordi C, D’Adda T, Azzoni C, et al. Hypergastrinemia and gastric enterochromaffin-like cells. Am J Surg Pathol. 1995;19(Suppl 1):S8–19.
6. Annibale B, Azzoni C, Corleto VD, et al. Atrophic body gastritis patients with enterochromaffin-like cell dysplasia are at increased risk for the development of type I gastric carcinoid. Eur J Gastroenterol Hepatol. 2001;13:1449–56.
7. Kokkola A, Sjöblom SM, Haapiainen R, et al. The risk of gastric carcinoma and carcinoid tumours in patients with pernicious anaemia. A prospective follow-up study. Scand J Gastroenterol. 1998;33:88–92.
8. Sjöblom SM, Sipponen P, Miettinen M, et al. Gastroscopic screening for gastric carcinoids and carcinoma in pernicious anemia. Endoscopy. 1988;20:52–6.
9. Vannella L, Sbrozzi-Vanni A, Lahner E, et al. Development of type I gastric carcinoid in patients with chronic atrophic gastritis. Aliment Pharmacol Ther. 2011;33:1361–9.
10. Sjöblom SM, Sipponen P, Järvinen H. Gastroscopic follow up of pernicious anaemia patients. Gut. 1993;34:28–32.
11. Armbrecht U, Stockbrügger RW, Rode J, et al. Development of gastric dysplasia in pernicious anaemia: a clinical and endoscopic follow up study of 80 patients. Gut. 1990;31:1105–9.
12. Stockbrügger RW, Menon GG, Beilby JO, et al. Gastroscopic screening in 80 patients with pernicious anaemia. Gut. 1983;24:1141–7.
13. Rugge M, Correa P, Dixon MF, Fiocca R, Hattori T, Lechago J, Leandro G, Price AB, Sipponen P, Solcia E, Watanabe H, Genta RM. Gastric mucosal atrophy: interobserver consistency using new criteria for classification and grading. Aliment Pharmacol Ther. 2002;16:1249–59.
14. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process. First American cancer society award lecture on cancer epidemiology and prevention. Cancer Res. 1992;52:6735–40.
15. Haber MM. Histologic precursors of gastrointestinal tract malignancy. Gastroenterol Clin North Am. 2002;31:395–419.
16. Whiting JL, Sigurdsson A, Rowlands DC, et al. The long term results of endoscopic surveillance of premalignant gastric lesions. Gut. 2002;50:378–81.
17. Dinis-Ribeiro M, Lopes C, da Costa-Pereira A, et al. A follow up model for patients with atrophic chronic gastritis and intestinal metaplasia. J Clin Pathol. 2004;57:177–82.
18. Vannella L, Lahner E, Osborn J, et al. Risk factors for progression to gastric neoplastic lesions in patients with atrophic gastritis. Aliment Pharmacol Ther. 2010;31:1042–50.
19. Ferlay J, Bray F, Pisani P, et al. GLOBOCAN 2002: Cancer incidence, mortality and prevalence worldwide. IARC Cancer Base n.5 version 2.0, IARC Press, Lyon, 2004.
20. Cunha P, Cunja JF, Burnay MO, et al. Gastric adenocarcinoma and carcinoid. Acta Med Port. 1998;11:577–80.
21. Olinici CD, Crisan D, Racu I. Synchronous gastric adenocarcinoma and carcinoid. Rom J Gastroenterol. 2004;13:135–7.
22. Maiorana A, Fante R, Cesinaro AM, et al. Synchronous occurrence of epithelial and stromal tumors in the stomach. Arch Pathol Lab Med. 2000;124:682–6.
23. Yang L, Zhang H-T, Zhang X, et al. Synchronous occurrence of carcinoid, signet-ring cell carcinoma and heterotopic pancreatic tissue in stomach: a case report and literature review. World J Gastroenterol. 2006;12:7216–20.
24. Valverde EM, Cebrian IM, Pastor BC, et al. Sinchronous multiple gastric carcinoid tumors and gastric adenocarcinoma. Rev Esp Enferm Dig. 2009;101:145–52.
25. Kim YE, Park KC, Kwon JG. A case of double primary cancer–early gastric adenocarcinoma associated with adenocarcinoma and carcinoid. Korean J Gastroenterol. 2003;42:533–8.
26. Adler AC, Cestero C, Lewis WH III, et al. Composite adenocarcinoma and carcinoid gastric tumor in chronic atrophic gastritis and pernicious anemia. Case Rep Gastroenterol. 2011;5:232–8.
27. Ünal B, Elpek GÖ, Gelen T, et al. Gastric collision tumor: case report of a rare adenocarcinoma and a typical carcinoid tumor. Oncology Letters. 2013;6:212–4.
28. Annibale B, Marignani M, Azzoni C, et al. Atrophic body gastritis: distinct features associated with Helicobacter pylori infection. Helicobacter. 1997;2:57–64.
29. Lahner E, Norman GL, Severi C, et al. Reassessment of intrinsic factor and parietal cell autoantibodies in atrophic gastritis with respect to cobalamin deficiency. Am J Gastroenterol. 2009;104:2071–9.
30. Lahner E, Centanni M, Agnello G, et al. Occurrence and risk factors for autoimmune thyroid disease in patients with atrophic body gastritis. Am J Med. 2008;121:136–41.
31. Solcia E, Bordi C, Creutzfeldt W, et al. Histopathological classification of nonantral gastric endocrine growths in man. Digestion. 1998;41:185–200.
32. Lahner E, Bordi C, Di Giulio E, et al. Role of H. pylori serology in atrophic body gastritis after eradication treatment. Aliment Pharmacol Ther. 2002;16:507–14.
33. Modlin IM, Lye KD, Kidd M. Carcinoid tumors of the stomach. Surg Oncol. 2003;12:153–72.
34. Dakin GF, Warner RR, Pomp A, et al. Presentation, treatment, and outcome of type 1 gastric carcinoid tumors. J Surg Oncol. 2006;93:368–72.
35. Schindl M, Kaserer K, Niederle B. Treatment of gastric neuroendocrine tumors: the necessity of a type-adapted treatment. Arch Surg. 2001;136:49–54.
36. Merola E, Sbrozzi Vanni A, Panzuto F, et al. Type I gastric carcinoids: a prospective study on endoscopic management and recurrence rate. Neuroendocrinology. 2011;95:207–13.
37. Waldum HL, Hauso O, Fossmark R. The regulation of gastric acid secretion – clinical perspectives. Acta Physiol (Oxf). 2013. doi:10.1111/apha.12208. [Epub ahead of print].
38. Fossmark R, Ovigstad G, Waldum HL. Gastric cancer: animal studies on the risk of hypoacidity and hypergastrinemia. World J Gastroenterol. 2008;14:1646–51.
39. Rugge M, Capelle LG, Cappellesso R, et al. Precancerous lesions in the stomach: from biology to clinical patient management. Best Pract Res Clin Gastroenterol. 2013;27:205–23.
40. Vannella L, Lahner E, Annibale B. Risk for gastric Risk for gastric neoplasias in patients with chronic atrophic gastritis: a critical reappraisal. World J Gastroenterol. 2012;18:1279–85.
41. Dixon MF, Genta RM, Yardley JH, et al. Classification and grading of gastritis. The updated Sydney system. International workshop on the histopathology of gastritis, Houston 1994. Am J Surg Pathol. 1996;20:1161–81.
42. Uemura N, Okamoto S, Yamamoto S, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med. 2001;13(345):784–9.
43. Vannella L, Lahner E, Osborn J, et al. Systematic review: gastric cancer incidence in pernicious anaemia. Aliment Pharmacol Ther. 2013;37:375–82.